Spectrum Pharmaceuticals Inc

SPPICIK 0000831547 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed May 1, 2023. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0001

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Spectrum Pharmaceuticals Inc

Name	Roles	Filings
Fischer Seth H. Z.	Director	2
Gustafson Kurt A	Officer	2
Lim Juhyun	Director	2
Vacirca Jeff L	Director	2
Bradrick Brittany	Director	1

Showing 6-10 of 11

Per pagePrevPage 2 of 3Next

All filings

36 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Aug 1, 2023	Lim Juhyun Director	DDisposition	29,759	-	-
Aug 1, 2023	McGahan Keith M See Remarks	DDisposition	195,485	-	-
Aug 1, 2023	Bradrick Brittany Director	DDisposition	27,380	-	-
May 30, 2023	Brennan Nora CFO	SSale	32,387	$1.096	$35,496
Mar 17, 2023	Riga Thomas J CEO & President · Director	SSale	31,381	$0.796	$24,979

Showing 6-10 of 36

Per pagePrevPage 2 of 8Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value